Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B286564-5mg | 5mg | In stock | $79.90 | |
B286564-10mg | 10mg | In stock | $129.90 | |
B286564-25mg | 25mg | In stock | $239.90 | |
B286564-50mg | 50mg | In stock | $439.90 | |
B286564-100mg | 100mg | In stock | $639.90 |
Potent, selective CCR1 antagonist
Synonyms | BX471 | BX-471 | BX-471 free base | BX 471 | (R)-1-(5-chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea | ZK-811752 | [5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methylpiperazin-1-yl]-2-oxoethoxy]phenyl]urea | BX-741 |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Efficient selective non peptide CCR1 antagonist (KI = 1 nm of human CCR1). The selectivity for CCR1 is 250 times that of CCR2, CCR5 and CXCR4. Inhibit MIP- α/ CCL3 induced intracellular Ca2 + mobilization. Effectively reduce the disease severity of multi |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of CCR1 |
Product Description | Product Application |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methylpiperazin-1-yl]-2-oxoethoxy]phenyl]urea |
---|---|
INCHI | InChI=1S/C21H24ClFN4O3/c1-14-11-26(12-15-2-5-17(23)6-3-15)8-9-27(14)20(28)13-30-19-7-4-16(22)10-18(19)25-21(24)29/h2-7,10,14H,8-9,11-13H2,1H3,(H3,24,25,29)/t14-/m1/s1 |
InChi Key | XQYASZNUFDVMFH-CQSZACIVSA-N |
Canonical SMILES | CC1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F |
Isomeric SMILES | C[C@@H]1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F |
PubChem CID | 512282 |
Molecular Weight | 434.89 |
PubChem CID | 512282 |
---|---|
ChEMBL Ligand | CHEMBL232656 |
CAS Registry No. | 217645-70-0 |
GPCRdb Ligand | BX 471 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2416212 | Certificate of Analysis | May 22, 2024 | B286564 |
G2416213 | Certificate of Analysis | May 22, 2024 | B286564 |
J2214466 | Certificate of Analysis | Jun 21, 2022 | B286564 |
J2214486 | Certificate of Analysis | Jun 21, 2022 | B286564 |
J2214505 | Certificate of Analysis | Jun 21, 2022 | B286564 |
J2214508 | Certificate of Analysis | Jun 21, 2022 | B286564 |
J2214519 | Certificate of Analysis | Jun 21, 2022 | B286564 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 43.49, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 21.74, Max Conc. mM: 50 |
---|---|
Sensitivity | Hygroscopic,Heat Sensitive |
Pictogram(s) | GHS09, GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed H400:Very toxic to aquatic life |
Precautionary Statements | P273:Avoid release to the environment. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P391:Collect spillage. P330:Rinse mouth. P301+P317:IF SWALLOWED: Get medical help. |
Starting at $318.90
1. Liang M, Mallari C, Rosser M, Ng HP, May K, Monahan S, Bauman JG, Islam I, Ghannam A, Buckman B et al.. (2000) Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1.. J Biol Chem, 275 (25): (19000-8). [PMID:10748002] [10.1021/op500134e] |
2. Anders HJ, Vielhauer V, Frink M, Linde Y, Cohen CD, Blattner SM, Kretzler M, Strutz F, Mack M, Gröne HJ et al.. (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.. J Clin Invest, 109 (2): (251-9). [PMID:11805137] [10.1021/op500134e] |
3. Furuichi K, Gao JL, Horuk R, Wada T, Kaneko S, Murphy PM. (2008) Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury.. J Immunol, 181 (12): (8670-6). [PMID:19050287] [10.1021/op500134e] |